# R&D Earning Screener - MongoDB ë°ì´í„°ë² ì´ìŠ¤ ì„¤ê³„ ë¬¸ì„œ

## ğŸ“‹ ëª©ì°¨
- [ê°œìš”](#ê°œìš”)
- [ë°ì´í„°ë² ì´ìŠ¤ êµ¬ì¡°](#ë°ì´í„°ë² ì´ìŠ¤-êµ¬ì¡°)
- [ì»¬ë ‰ì…˜ ìƒì„¸ ì„¤ê³„](#ì»¬ë ‰ì…˜-ìƒì„¸-ì„¤ê³„)
- [ë°ì´í„° ê´€ê³„ë„](#ë°ì´í„°-ê´€ê³„ë„)
- [ì¸ë±ìŠ¤ ì„¤ê³„](#ì¸ë±ìŠ¤-ì„¤ê³„)
- [ë°ì´í„° íƒ€ì… ë° ë‹¨ìœ„ ê·œì¹™](#ë°ì´í„°-íƒ€ì…-ë°-ë‹¨ìœ„-ê·œì¹™)

---

## ê°œìš”

### ë°ì´í„°ë² ì´ìŠ¤ëª…
`rnd_earning_screener`

### í•µì‹¬ ì„¤ê³„ ì›ì¹™
1. **ìˆ«ì ê¸°ë°˜ ì €ì¥**: ëª¨ë“  ê¸ˆì•¡, ë¹„ìœ¨ì€ ìˆ«ìë¡œ ì €ì¥ (ë¶„ì„ ë° ì§‘ê³„ ê°€ëŠ¥)
2. **ëª…í™•í•œ ë‹¨ìœ„**: ë°±ë§Œì› ë‹¨ìœ„ë¡œ í†µì¼
3. **1:N ê´€ê³„**: 1ê°œ ê¸°ì—… â†’ Nê°œ ê¸°ìˆ 
4. **ì°¸ì¡° ë¬´ê²°ì„±**: companyId, technologyIdë¡œ ì—°ê²°
5. **í™•ì¥ ê°€ëŠ¥**: ìƒˆ í•„ë“œ ì¶”ê°€ ìš©ì´

---

## ë°ì´í„°ë² ì´ìŠ¤ êµ¬ì¡°

### ì „ì²´ ì»¬ë ‰ì…˜ (4ê°œ)

| ì»¬ë ‰ì…˜ëª… | ì—­í•  | ë¬¸ì„œ ìˆ˜ ì˜ˆìƒ | ê´€ê³„ |
|---------|------|------------|------|
| `companies` | ê¸°ì—… ê¸°ë³¸ì •ë³´ + ì¬ë¬´ | ìˆ˜ë°±~ìˆ˜ì²œ | 1 |
| `technologies` | ê¸°ìˆ ì •ë³´ + R&D + ì‚¬ì—…í™” | ìˆ˜ì²œ~ìˆ˜ë§Œ | N (belongs to company) |
| `commercialization_records` | ì‚¬ì—…í™” ê±°ë˜ ì´ë ¥ | ìˆ˜ì²œ~ìˆ˜ë§Œ | N (belongs to technology) |
| `bc_ratio_history` | B/C ë¹„ìœ¨ ì‹œê³„ì—´ | ìˆ˜ë§Œ~ìˆ˜ì‹­ë§Œ | N (belongs to technology) |

---

## ì»¬ë ‰ì…˜ ìƒì„¸ ì„¤ê³„

### 1ï¸âƒ£ companies (ê¸°ì—… ì»¬ë ‰ì…˜)

**ëª©ì **: ê¸°ì—…ì˜ ê¸°ë³¸ ì •ë³´ì™€ ì „ì‚¬ ì¬ë¬´ ë°ì´í„° ê´€ë¦¬

#### í•„ë“œ êµ¬ì¡°

| í•„ë“œëª… | íƒ€ì… | í•„ìˆ˜ | ì„¤ëª… | ì˜ˆì‹œ | ë‹¨ìœ„/í˜•ì‹ |
|--------|------|------|------|------|----------|
| `_id` | ObjectId | âœ… | MongoDB ìë™ ìƒì„± ID | - | - |
| `companyId` | String | âœ… | ê¸°ì—… ê³ ìœ  ì‹ë³„ì | "comp_biogen_korea" | unique |
| `name` | String | âœ… | ê¸°ì—…ëª… | "ë°”ì´ì˜¤ì  ì½”ë¦¬ì•„" | - |
| `industry` | String | âœ… | ì‚°ì—… ë¶„ë¥˜ | "ë°”ì´ì˜¤ê¸°ìˆ " | - |
| `totalAssets` | Number | âœ… | ì´ ìì‚° | 2400000 | ë°±ë§Œì› (2.4ì¡°) |
| `employeeCount` | Number | âœ… | ì§ì› ìˆ˜ | 1250 | ëª… |
| `foundedYear` | Number | âœ… | ì„¤ë¦½ ì—°ë„ | 2018 | 4ìë¦¬ ì—°ë„ |
| `location` | String | âŒ | ìƒì„¸ ìœ„ì¹˜ | "ê²½ê¸°ë„ ì„±ë‚¨ì‹œ" | - |
| `region` | String | âŒ | ì§€ì—­ | "ê²½ê¸°" | - |
| `ceo` | String | âŒ | ëŒ€í‘œìëª… | "ê¹€ë°”ì´ì˜¤" | - |
| `website` | String | âŒ | ì›¹ì‚¬ì´íŠ¸ | "www.biogenkorea.com" | - |
| `fundingStage` | String | âŒ | í€ë”© ë‹¨ê³„ | "growth", "public" | - |
| `financials` | Object | âœ… | ì¬ë¬´ ì •ë³´ ê°ì²´ | ì•„ë˜ ì°¸ì¡° | - |
| `financialHistory` | Array | âœ… | ì—°ë„ë³„ ì¬ë¬´ ì´ë ¥ | ì•„ë˜ ì°¸ì¡° | - |
| `createdAt` | Date | âœ… | ìƒì„± ì¼ì‹œ | ISODate("2024-01-01") | - |
| `updatedAt` | Date | âœ… | ìˆ˜ì • ì¼ì‹œ | ISODate("2024-01-15") | - |

#### financials ê°ì²´ êµ¬ì¡°

| í•„ë“œëª… | íƒ€ì… | í•„ìˆ˜ | ì„¤ëª… | ì˜ˆì‹œ | ë‹¨ìœ„ |
|--------|------|------|------|------|------|
| `revenue` | Number | âœ… | ì „ì‚¬ ë§¤ì¶œ | 850000 | ë°±ë§Œì› (8500ì–µ) |
| `rdInvestment` | Number | âœ… | ì „ì‚¬ R&D íˆ¬ì | 127000 | ë°±ë§Œì› (1270ì–µ) |
| `profitMargin` | Number | âœ… | ì˜ì—…ì´ìµë¥  | 15.2 | % |
| `revenueGrowth` | Number | âœ… | ë§¤ì¶œ ì„±ì¥ë¥  | 23.4 | % |

#### financialHistory ë°°ì—´ êµ¬ì¡°

| í•„ë“œëª… | íƒ€ì… | í•„ìˆ˜ | ì„¤ëª… | ì˜ˆì‹œ | ë‹¨ìœ„ |
|--------|------|------|------|------|------|
| `year` | Number | âœ… | ì—°ë„ | 2023 | 4ìë¦¬ |
| `revenue` | Number | âœ… | í•´ë‹¹ ì—°ë„ ë§¤ì¶œ | 850000 | ë°±ë§Œì› |
| `assets` | Number | âœ… | í•´ë‹¹ ì—°ë„ ìì‚° | 240000 | ë°±ë§Œì› |
| `operatingProfit` | Number | âœ… | ì˜ì—…ì´ìµ | 129200 | ë°±ë§Œì› |
| `rdInvestment` | Number | âœ… | R&D íˆ¬ì | 127000 | ë°±ë§Œì› |

---

### 2ï¸âƒ£ technologies (ê¸°ìˆ  ì»¬ë ‰ì…˜)

**ëª©ì **: ê¸°ìˆ ë³„ ìƒì„¸ ì •ë³´, R&D íˆ¬ì, ì‚¬ì—…í™” ì‹¤ì  ê´€ë¦¬

#### í•„ë“œ êµ¬ì¡°

| í•„ë“œëª… | íƒ€ì… | í•„ìˆ˜ | ì„¤ëª… | ì˜ˆì‹œ | ë‹¨ìœ„/í˜•ì‹ |
|--------|------|------|------|------|----------|
| `_id` | ObjectId | âœ… | MongoDB ìë™ ìƒì„± ID | - | - |
| `technologyId` | String | âœ… | ê¸°ìˆ  ê³ ìœ  ì‹ë³„ì | "tech_cancer_immuno_001" | unique |
| `companyId` | String | âœ… | ì†Œì† ê¸°ì—… ID (FK) | "comp_biogen_korea" | ì™¸ë˜í‚¤ |
| `name` | String | âœ… | ê¸°ìˆ ëª… | "ì°¨ì„¸ëŒ€ ì•” ë©´ì—­ì¹˜ë£Œê¸°ìˆ " | - |
| `description` | String | âŒ | ê¸°ìˆ  ì„¤ëª… | "í˜ì‹ ì ì¸ CAR-T ì„¸í¬..." | - |
| `category` | String | âœ… | ê¸°ìˆ  ë¶„ë¥˜ | "ë°”ì´ì˜¤ê¸°ìˆ " | - |
| `developmentPeriod` | Object | âœ… | ê°œë°œ ê¸°ê°„ | ì•„ë˜ ì°¸ì¡° | - |
| `trlLevel` | Number | âœ… | ê¸°ìˆ ì„±ìˆ™ë„ | 8 | 1-9 |
| `commercializationStatus` | String | âœ… | ì‚¬ì—…í™” ìƒíƒœ | "verified" | verified/in-progress/planned |
| `rdData` | Object | âœ… | R&D íˆ¬ì ì •ë³´ | ì•„ë˜ ì°¸ì¡° | - |
| `commercialization` | Object | âœ… | ì‚¬ì—…í™” ì‹¤ì  ì •ë³´ | ì•„ë˜ ì°¸ì¡° | - |
| `performance` | Object | âŒ | ì„±ê³¼ ì§€í‘œ | ì•„ë˜ ì°¸ì¡° | - |
| `createdAt` | Date | âœ… | ìƒì„± ì¼ì‹œ | - | - |
| `updatedAt` | Date | âœ… | ìˆ˜ì • ì¼ì‹œ | - | - |

#### developmentPeriod ê°ì²´ êµ¬ì¡°

| í•„ë“œëª… | íƒ€ì… | í•„ìˆ˜ | ì„¤ëª… | ì˜ˆì‹œ |
|--------|------|------|------|------|
| `startYear` | Number | âœ… | ê°œë°œ ì‹œì‘ ì—°ë„ | 2019 |
| `endYear` | Number | âœ… | ê°œë°œ ì¢…ë£Œ ì—°ë„ | 2023 |

#### rdData ê°ì²´ êµ¬ì¡°

| í•„ë“œëª… | íƒ€ì… | í•„ìˆ˜ | ì„¤ëª… | ì˜ˆì‹œ | ë‹¨ìœ„ |
|--------|------|------|------|------|------|
| `totalInvestment` | Number | âœ… | ì´ R&D íˆ¬ì | 3200 | ë°±ë§Œì› (32ì–µ) |
| `investmentByYear` | Array | âŒ | ì—°ë„ë³„ íˆ¬ì | [{year: 2020, amount: 850}] | ë°±ë§Œì› |
| `teamSize` | Number | âŒ | ì—°êµ¬ ì¸ë ¥ | 15 | ëª… |
| `facilities` | String | âŒ | ì—°êµ¬ ì‹œì„¤ | "ì„±ë‚¨ R&D ì„¼í„°" | - |

#### commercialization ê°ì²´ êµ¬ì¡°

| í•„ë“œëª… | íƒ€ì… | í•„ìˆ˜ | ì„¤ëª… | ì˜ˆì‹œ | ë‹¨ìœ„ |
|--------|------|------|------|------|------|
| `totalRevenue` | Number | âœ… | ì´ ì‚¬ì—…í™” ìˆ˜ìµ | 15040 | ë°±ë§Œì› (150.4ì–µ) |
| `bcRatio` | Number | âœ… | B/C ë¹„ìœ¨ | 4.7 | ë°°ìˆ˜ |
| `revenueByYear` | Array | âŒ | ì—°ë„ë³„ ìˆ˜ìµ | [{year: 2024, revenue: 9400}] | ë°±ë§Œì› |

#### performance ê°ì²´ êµ¬ì¡°

| í•„ë“œëª… | íƒ€ì… | í•„ìˆ˜ | ì„¤ëª… | ì˜ˆì‹œ | ë‹¨ìœ„ |
|--------|------|------|------|------|------|
| `patentsFiled` | Number | âŒ | ì¶œì› íŠ¹í—ˆ ìˆ˜ | 24 | ê±´ |
| `patentsGrowthRate` | Number | âŒ | íŠ¹í—ˆ ì¦ê°€ìœ¨ | 15 | % |
| `technologyTransfers` | Number | âŒ | ê¸°ìˆ ì´ì „ ê±´ìˆ˜ | 8 | ê±´ |
| `transfersGrowthRate` | Number | âŒ | ê¸°ìˆ ì´ì „ ì¦ê°€ìœ¨ | 60 | % |
| `licensingRevenue` | Number | âŒ | ë¼ì´ì„ ì‹± ìˆ˜ìµ | 1200 | ë°±ë§Œì› |
| `licensingGrowthRate` | Number | âŒ | ë¼ì´ì„ ì‹± ì¦ê°€ìœ¨ | 85 | % |
| `commercialProducts` | Number | âŒ | ìƒìš©í™” ì œí’ˆ ìˆ˜ | 12 | ê°œ |
| `productsGrowthRate` | Number | âŒ | ì œí’ˆ ì¦ê°€ìœ¨ | 33 | % |

---

### 3ï¸âƒ£ commercialization_records (ì‚¬ì—…í™” ì‹¤ì  ì»¬ë ‰ì…˜)

**ëª©ì **: ê¸°ìˆ ë³„ ì‚¬ì—…í™” ê±°ë˜ ìƒì„¸ ì´ë ¥ ê´€ë¦¬

#### í•„ë“œ êµ¬ì¡°

| í•„ë“œëª… | íƒ€ì… | í•„ìˆ˜ | ì„¤ëª… | ì˜ˆì‹œ | ë‹¨ìœ„ |
|--------|------|------|------|------|------|
| `_id` | ObjectId | âœ… | MongoDB ìë™ ìƒì„± ID | - | - |
| `commercializationId` | String | âœ… | ì‚¬ì—…í™” ì‹¤ì  ID | "comm_001" | unique |
| `technologyId` | String | âœ… | ê¸°ìˆ  ID (FK) | "tech_cancer_immuno_001" | ì™¸ë˜í‚¤ |
| `companyId` | String | âœ… | ê¸°ì—… ID (FK) | "comp_biogen_korea" | ì™¸ë˜í‚¤ |
| `client` | String | âœ… | ê±°ë˜ì²˜ | "ì‚¼ì„±ì „ì" | - |
| `dealType` | String | âœ… | ê±°ë˜ ìœ í˜• | "ë¼ì´ì„ ì‹±" | ê¸°ìˆ ì´ì „/ë¼ì´ì„ ì‹±/ê³µë™ê°œë°œ |
| `dealYear` | Number | âœ… | ê±°ë˜ ì—°ë„ | 2023 | 4ìë¦¬ |
| `dealValue` | Number | âœ… | ê±°ë˜ ê¸ˆì•¡ | 450 | ë°±ë§Œì› (4.5ì–µ) |
| `revenueType` | String | âœ… | ìˆ˜ìµ ìœ í˜• | "annual" | annual/one-time |
| `status` | String | âœ… | ì§„í–‰ ìƒíƒœ | "active" | active/completed |
| `createdAt` | Date | âœ… | ìƒì„± ì¼ì‹œ | - | - |

---

### 4ï¸âƒ£ bc_ratio_history (B/C ë¹„ìœ¨ ì´ë ¥ ì»¬ë ‰ì…˜)

**ëª©ì **: ê¸°ìˆ ë³„ B/C ë¹„ìœ¨ ì‹œê³„ì—´ ë°ì´í„° ì¶”ì 

#### í•„ë“œ êµ¬ì¡°

| í•„ë“œëª… | íƒ€ì… | í•„ìˆ˜ | ì„¤ëª… | ì˜ˆì‹œ | ë‹¨ìœ„ |
|--------|------|------|------|------|------|
| `_id` | ObjectId | âœ… | MongoDB ìë™ ìƒì„± ID | - | - |
| `historyId` | String | âœ… | ì´ë ¥ ID | "hist_001" | unique |
| `technologyId` | String | âœ… | ê¸°ìˆ  ID (FK) | "tech_cancer_immuno_001" | ì™¸ë˜í‚¤ |
| `companyId` | String | âœ… | ê¸°ì—… ID (FK) | "comp_biogen_korea" | ì™¸ë˜í‚¤ |
| `year` | Number | âœ… | ì—°ë„ | 2024 | 4ìë¦¬ |
| `bcRatio` | Number | âœ… | B/C ë¹„ìœ¨ | 4.7 | ë°°ìˆ˜ |
| `investment` | Number | âœ… | íˆ¬ì ê¸ˆì•¡ | 2000 | ë°±ë§Œì› |
| `revenue` | Number | âœ… | ìˆ˜ìµ ê¸ˆì•¡ | 9400 | ë°±ë§Œì› |
| `createdAt` | Date | âœ… | ìƒì„± ì¼ì‹œ | - | - |

---

## ë°ì´í„° ê´€ê³„ë„

### ERD (Entity Relationship Diagram)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚     companies       â”‚
â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€ â”‚
â”‚ companyId (PK)      â”‚â—„â”€â”
â”‚ name                â”‚  â”‚
â”‚ industry            â”‚  â”‚
â”‚ totalAssets         â”‚  â”‚
â”‚ financials          â”‚  â”‚
â”‚ financialHistory[]  â”‚  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
                         â”‚ 1:N
                         â”‚
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚   technologies      â”‚  â”‚
â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€ â”‚  â”‚
â”‚ technologyId (PK)   â”‚  â”‚
â”‚ companyId (FK)      â”‚â”€â”€â”˜
â”‚ name                â”‚â—„â”€â”
â”‚ category            â”‚  â”‚
â”‚ rdData              â”‚  â”‚
â”‚ commercialization   â”‚  â”‚
â”‚ performance         â”‚  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
         â–²               â”‚
         â”‚ 1:N           â”‚ 1:N
         â”‚               â”‚
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”‚
â”‚ bc_ratio_history  â”‚    â”‚
â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚     â”‚
â”‚ historyId (PK)    â”‚    â”‚
â”‚ technologyId (FK) â”‚    â”‚
â”‚ year              â”‚    â”‚
â”‚ bcRatio           â”‚    â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â”‚
                         â”‚
        â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
        â”‚ 1:N
        â”‚
â”Œâ”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ commercialization_records â”‚
â”‚ â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€ â”‚
â”‚ commercializationId (PK)  â”‚
â”‚ technologyId (FK)         â”‚
â”‚ client                    â”‚
â”‚ dealValue                 â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### ê´€ê³„ ì„¤ëª…

| ê´€ê³„ | ì„¤ëª… | ì¹´ë””ë„ë¦¬í‹° |
|------|------|-----------|
| companies â†” technologies | ê¸°ì—…ì´ ì—¬ëŸ¬ ê¸°ìˆ  ë³´ìœ  | 1:N |
| technologies â†” commercialization_records | ê¸°ìˆ ë‹¹ ì—¬ëŸ¬ ê±°ë˜ ê¸°ë¡ | 1:N |
| technologies â†” bc_ratio_history | ê¸°ìˆ ë‹¹ ì—¬ëŸ¬ ì—°ë„ ì´ë ¥ | 1:N |

---

## ì¸ë±ìŠ¤ ì„¤ê³„

### companies ì¸ë±ìŠ¤

| í•„ë“œ | íƒ€ì… | ëª©ì  |
|------|------|------|
| `companyId` | unique | ê³ ìœ  ì‹ë³„, ê¸°ë³¸í‚¤ |
| `industry` | ì¼ë°˜ | ì‚°ì—…ë³„ í•„í„°ë§ |
| `region` | ì¼ë°˜ | ì§€ì—­ë³„ í•„í„°ë§ |
| `name` | text | í…ìŠ¤íŠ¸ ê²€ìƒ‰ |
| `(region, industry)` | compound | ë³µí•© ì¿¼ë¦¬ ìµœì í™” |

### technologies ì¸ë±ìŠ¤

| í•„ë“œ | íƒ€ì… | ëª©ì  |
|------|------|------|
| `technologyId` | unique | ê³ ìœ  ì‹ë³„, ê¸°ë³¸í‚¤ |
| `companyId` | ì¼ë°˜ | ê¸°ì—…ë³„ ê¸°ìˆ  ì¡°íšŒ |
| `commercialization.bcRatio` | ì¼ë°˜ | B/C ratio ì •ë ¬ |
| `category` | ì¼ë°˜ | ê¸°ìˆ  ë¶„ë¥˜ë³„ ì¡°íšŒ |
| `name, description` | text | í…ìŠ¤íŠ¸ ê²€ìƒ‰ |
| `(companyId, commercializationStatus)` | compound | ê¸°ì—…ë³„ ìƒíƒœ ì¡°íšŒ |

### commercialization_records ì¸ë±ìŠ¤

| í•„ë“œ | íƒ€ì… | ëª©ì  |
|------|------|------|
| `commercializationId` | unique | ê³ ìœ  ì‹ë³„ |
| `technologyId` | ì¼ë°˜ | ê¸°ìˆ ë³„ ì¡°íšŒ |
| `(technologyId, dealYear)` | compound | ê¸°ìˆ ë³„ ì—°ë„ë³„ ì¡°íšŒ |
| `companyId` | ì¼ë°˜ | ê¸°ì—…ë³„ ì¡°íšŒ |

### bc_ratio_history ì¸ë±ìŠ¤

| í•„ë“œ | íƒ€ì… | ëª©ì  |
|------|------|------|
| `(technologyId, year)` | compound, unique | ì‹œê³„ì—´ ì¡°íšŒ, ì¤‘ë³µ ë°©ì§€ |
| `companyId` | ì¼ë°˜ | ê¸°ì—…ë³„ ì¡°íšŒ |

---

## ë°ì´í„° íƒ€ì… ë° ë‹¨ìœ„ ê·œì¹™

### ê³µí†µ ê·œì¹™

| ë°ì´í„° ì¢…ë¥˜ | ì €ì¥ íƒ€ì… | ì €ì¥ ë‹¨ìœ„ | í‘œì‹œ ì˜ˆì‹œ | ë¹„ê³  |
|-----------|---------|---------|----------|------|
| **ê¸ˆì•¡** | Number | ë°±ë§Œì› | 850000 â†’ "â‚©8,500ì–µ" | ì†Œìˆ˜ì  ì—†ìŒ |
| **í¼ì„¼íŠ¸** | Number | ì†Œìˆ˜ì  | 15.2 â†’ "15.2%" | ì†Œìˆ˜ì  1ìë¦¬ |
| **ì—°ë„** | Number | 4ìë¦¬ | 2024 | YYYY í˜•ì‹ |
| **ì¸ì›** | Number | ëª… | 1250 â†’ "1,250ëª…" | ì •ìˆ˜ |
| **ë¹„ìœ¨** | Number | ë°°ìˆ˜ | 4.7 â†’ "4.7x" | ì†Œìˆ˜ì  1ìë¦¬ |

### ê¸ˆì•¡ ë³€í™˜ ì˜ˆì‹œ

| DB ê°’ (ë°±ë§Œì›) | ì–µì› | ì¡°ì› | í‘œì‹œ í˜•ì‹ |
|--------------|------|------|----------|
| 850 | 8.5 | 0.00085 | â‚©8.5ì–µ |
| 850000 | 8500 | 0.85 | â‚©8,500ì–µ |
| 2400000 | 24000 | 2.4 | â‚©2.4ì¡° |

### Enum ê°’ ì •ì˜

#### commercializationStatus
- `verified`: ê²€ì¦ ì™„ë£Œ
- `in-progress`: ì§„í–‰ ì¤‘
- `planned`: ê³„íš ì¤‘

#### dealType
- `ê¸°ìˆ ì´ì „`: Technology Transfer
- `ë¼ì´ì„ ì‹±`: Licensing
- `ê³µë™ê°œë°œ`: Joint Development

#### revenueType
- `annual`: ì—°ê°„ ìˆ˜ìµ
- `one-time`: ì¼íšŒì„± ìˆ˜ìµ

#### status
- `active`: ì§„í–‰ ì¤‘
- `completed`: ì™„ë£Œ

---

## ìƒ˜í”Œ ë°ì´í„° êµ¬ì¡°

### companies ìƒ˜í”Œ
```json
{
  "_id": ObjectId("..."),
  "companyId": "comp_biogen_korea",
  "name": "ë°”ì´ì˜¤ì  ì½”ë¦¬ì•„",
  "industry": "ë°”ì´ì˜¤ê¸°ìˆ ",
  "totalAssets": 2400000,
  "employeeCount": 1250,
  "foundedYear": 2018,
  "location": "ê²½ê¸°ë„ ì„±ë‚¨ì‹œ",
  "region": "ê²½ê¸°",
  "ceo": "ê¹€ë°”ì´ì˜¤",
  "website": "www.biogenkorea.com",
  "fundingStage": "growth",
  "financials": {
    "revenue": 850000,
    "rdInvestment": 127000,
    "profitMargin": 15.2,
    "revenueGrowth": 23.4
  },
  "financialHistory": [
    {
      "year": 2020,
      "revenue": 420000,
      "assets": 180000,
      "operatingProfit": 63000,
      "rdInvestment": 84000
    },
    {
      "year": 2023,
      "revenue": 850000,
      "assets": 240000,
      "operatingProfit": 129200,
      "rdInvestment": 127000
    }
  ],
  "createdAt": ISODate("2024-01-01T00:00:00Z"),
  "updatedAt": ISODate("2024-01-15T10:30:00Z")
}
```

### technologies ìƒ˜í”Œ
```json
{
  "_id": ObjectId("..."),
  "technologyId": "tech_cancer_immuno_001",
  "companyId": "comp_biogen_korea",
  "name": "ì°¨ì„¸ëŒ€ ì•” ë©´ì—­ì¹˜ë£Œê¸°ìˆ ",
  "description": "Novel CAR-T cell therapy platform",
  "category": "ë°”ì´ì˜¤ê¸°ìˆ ",
  "developmentPeriod": {
    "startYear": 2019,
    "endYear": 2023
  },
  "trlLevel": 8,
  "commercializationStatus": "verified",
  "rdData": {
    "totalInvestment": 3200,
    "investmentByYear": [
      { "year": 2020, "amount": 850 },
      { "year": 2023, "amount": 1800 }
    ],
    "teamSize": 15,
    "facilities": "ì„±ë‚¨ R&D ì„¼í„°"
  },
  "commercialization": {
    "totalRevenue": 15040,
    "bcRatio": 4.7,
    "revenueByYear": [
      { "year": 2020, "revenue": 680 },
      { "year": 2024, "revenue": 9400 }
    ]
  },
  "performance": {
    "patentsFiled": 24,
    "patentsGrowthRate": 15,
    "technologyTransfers": 8,
    "transfersGrowthRate": 60,
    "licensingRevenue": 1200,
    "licensingGrowthRate": 85,
    "commercialProducts": 12,
    "productsGrowthRate": 33
  },
  "createdAt": ISODate("2024-01-01T00:00:00Z"),
  "updatedAt": ISODate("2024-01-15T10:30:00Z")
}
```

---

## ì„¤ê³„ íŠ¹ì§• ìš”ì•½

### âœ… ì¥ì 
1. **ë¶„ì„ ì¹œí™”ì **: ëª¨ë“  ìˆ˜ì¹˜ ë°ì´í„°ê°€ ìˆ«ìí˜•
2. **í™•ì¥ ê°€ëŠ¥**: ìƒˆ í•„ë“œ ì¶”ê°€ ìš©ì´
3. **ì„±ëŠ¥ ìµœì í™”**: ì ì ˆí•œ ì¸ë±ìŠ¤ ì„¤ê³„
4. **ë°ì´í„° ë¬´ê²°ì„±**: ì™¸ë˜í‚¤ ê´€ê³„ ëª…í™•
5. **ìœ ì—°ì„±**: MongoDBì˜ ìŠ¤í‚¤ë§ˆë¦¬ìŠ¤ íŠ¹ì„± í™œìš©

### ğŸ¯ í•µì‹¬ ì„¤ê³„ í¬ì¸íŠ¸
- **ë‹¨ìœ„ í†µì¼**: ê¸ˆì•¡ì€ ë°±ë§Œì›ìœ¼ë¡œ í†µì¼
- **1:N ê´€ê³„**: companyId, technologyIdë¡œ ì—°ê²°
- **Embedded vs Referenced**: ìì£¼ ì¡°íšŒë˜ëŠ” ë°ì´í„°ëŠ” Embedded, ë…ë¦½ ê´€ë¦¬ëŠ” Referenced
- **ì„±ëŠ¥**: B/C ratio, category ë“± ìì£¼ ê²€ìƒ‰ë˜ëŠ” í•„ë“œì— ì¸ë±ìŠ¤

---

